Achieve life sciences announces phase 3 orca-2 trial of cytisinicline in smoking cessation clears final review by data safety monitoring committee (dsmc)

Following the fifth and final dsmc review, committee has concluded no concerns with cytisinicline safety or phase 3 trial conduct following the fifth and final dsmc review, committee has concluded no concerns with cytisinicline safety or phase 3 trial conduct
ACHV Ratings Summary
ACHV Quant Ranking